Project Details
Description
In this ERC-funded project, we use novel biomarkers and imaging methods to improve the development of novel disease-modifying therapies for Alzheimer’s disease.
| Acronym | ADVANCE-AD |
|---|---|
| Status | Active |
| Effective start/end date | 2024/01/01 → 2028/12/31 |
Funding
- European Commission - Horizon Europe

- Swedish Research Council
